Biosimilars Experts 2025

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Founder of MDx CRO a specialized clinical research and regulatory consultancy dedicated to the medtech IVD sector. As a seasoned consultant in clinical and regulatory affairs, I am experienced in navigating complex regulatory challenges for top IVD companies. I have the privilege of serving as an external expert for the EU Commission and having lead global regulatory projects at BSI, one of the largest Notified Bodies as an IVDR CE mark technical expert. My portfolio of satisfied clients includes renowned companies such as Biomerieux, Cepheid, Leica (Danaher), Hologic, Grifols, Abbott, Beckman Coulter, ThermoFisher Scientific, Instrumentation Laboratory (Werfen), Roche Diagnostics, Alere, and more. I am passionate about simplifying science and regulation for my clients, delivering tailored solutions that help them stay ahead of the competition. My secret to success is building relationships based on trust, expertise and kindness. My clinical background, combined with 15+ years in the IVD industry and regulatory authorities, makes me a valuable resource for clients of all sizes. Let's connect and find out how I can help you navigate the ever-evolving world of IVD and MedTech 💬

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

*Board-Certified Family Medicine Physician (ABFM) with 14+ years clinical experience (based in Chicago, IL) *Named Castle Connolly Top Doctor (2024, 2025) *Medical Media Commentator seen on/in ABC 7, Fox 32, CBS 2, WGN 9, The Chicago Tribune , Chicago Sun Times, and Everyday Health; including a nationwide 25 interview satellite media tour (TV & radio, November 2025) *Premedical Student Mentor, Urban Bridges Medical Mentoring Program Dr. Rene is a board-certified Family Medicine physician and Fellow of the American Academy of Family Physicians (FAAFP) with 14+ years of clinical experience. She provides comprehensive primary care for Medicare-eligible patients at Oak Street Health's Avalon Park location in Chicago, specializing in chronic disease management, preventive care, healthcare equity, and access for underserved communities. After overcoming 50 medical school rejections, Dr. Rene graduated from Indiana University School of Medicine and completed residency training at Ascension Saint Joseph Hospital - Chicago. She developed the L.Y.M.I.T.S. Method—a framework for transforming limitations into your greatest strengths. She mentors aspiring physicians through the Urban Bridges Medical Mentoring Program. Dr. Rene has appeared as a medical expert on ABC 7, Fox 32, CBS 2, and WGN 9 Chicago and recently completed a 25-interview national satellite media tour. She is available for expert commentary on resilience in healthcare, medical education equity, resilience and overcoming failure, healthcare access for underserved populations, and diversity in medicine.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Dr. Yoon Hang “John” Kim is a board-certified integrative medicine physician with over 20 years of clinical experience dedicated to root-cause, patient-centered care. He is widely recognized as one of the leading clinical experts on Low-Dose Naltrexone (LDN) therapy, having authored three books and more than 20 articles on the subject, and leads the LDN Support Group—a thriving community of over 7,000 members. Dr. Kim completed his Integrative Medicine Fellowship at the University of Arizona’s Andrew Weil Center for Integrative Medicine, where he trained under the mentorship of Dr. Andrew Weil as a prestigious Osher Fellow. He holds board certifications in both Preventive Medicine and Integrative/Holistic Medicine, along with certification in Medical Acupuncture from UCLA. He was also a scholarship recipient from the Institute for Functional Medicine (IFM), further deepening his expertise in functional medicine approaches to complex chronic conditions. His clinical expertise spans integrative oncology—informed by deeply personal experience supporting family members who are now cancer survivors—chronic pain management, and the treatment of complex conditions including SIBO, MCAS, and autoimmune disorders. He brings a unique combination of conventional medical rigor and evidence-based complementary therapies to every patient encounter. Dr. Kim is the founder of Direct Integrative Care, a membership-based telemedicine practice that deliberately limits enrollment to ensure deep, personalized physician-patient relationships. His practice serves patients across six states—Iowa, Illinois, Missouri, Texas, Georgia, and Florida—operating entirely outside the constraints of insurance systems to preserve clinical independence and patient-first decision-making. A featured speaker at the LDN Research Trust conferences, Dr. Kim is a passionate educator who shares his expertise through his clinical and professional websites, a YouTube channel, and educational platforms including LDNSupportGroup.com. His personal motto—“Luck favors the prepared bold”—reflects his commitment to courage, preparation, and innovation in medicine.

Dr. Roderick Davies is the founder of Optum Dental Arts and a leading expert in dental implants, full-arch reconstruction, digital workflows, and patient anxiety solutions. He is known for advancing comfort-centered, technology-driven dentistry through his Lifetime Care Philosophy.

Tomo Marjanovic is the Founder and CEO of Aspire Rejuvenation Clinic, a multi-million dollar hormone optimization and regenerative medicine company with clinics in four U.S. cities and expansion underway in Cleveland and Dubai. Named a Top 100 Healthcare Visionary by IFAH, Marjanovic has treated thousands of patients through bioidentical HRT, peptide therapy, stem cell and exosome treatments, and medical weight loss programs. Before building Aspire, Marjanovic spent 12 years in law enforcement in Ohio and Florida, earning the Public Safety Medal of Valor. After chronic night shift work destroyed his hormonal health and the medical system failed to help, he got certified in Advanced Bioidentical Hormone Replacement Therapy through Worldlink Medical and built the company he wished existed when he was the patient. Marjanovic is the author of "Operation Optimal: Health, Wellness, & Becoming Your Best You" and host of the Tomo Talks podcast. He holds a BA in Criminal Justice Administration (Cum Laude) from Tiffin University and is a former competitive bodybuilder. His work has been featured in USA Today, NY Post, Miami Herald, Modern Luxury, and Authority Magazine. He is available to speak on hormone optimization, testosterone therapy, longevity medicine, regenerative therapies, peptides, men's health, stress and cortisol, health entrepreneurship, veteran and first responder wellness, the GLP-1 market, healthcare franchising, and the intersection of health and wealth.

Dr. Shiv Goel, MD is a board-certified physician and the founder of Prime Vitality Care, a physician-led functional medicine and wellness clinic based in San Antonio, Texas, with telehealth services available to patients in all 50 states. Dr. Goel trained in internal medicine and functional and integrative medicine, and has spent his career building a practice model that treats the root causes of poor health rather than managing symptoms in isolation. His clinical philosophy is grounded in the understanding that hormones, metabolism, inflammation, gut health, and mental well-being are deeply interconnected systems — and that lasting health improvements require addressing all of them together. Prime Vitality Care specializes in physician-supervised GLP-1 medical weight loss programs using semaglutide and tirzepatide, bioidentical hormone replacement therapy (BHRT) for women, testosterone replacement therapy (TRT) for men, peptide therapy including Sermorelin, BPC-157, and PT-141, and comprehensive functional medicine consultations for patients with chronic fatigue, gut dysfunction, autoimmune concerns, and metabolic disease. Dr. Goel is a sought-after expert on the clinical application of GLP-1 therapies, the role of hormonal imbalance in weight resistance, and the future of physician-led telehealth medicine. He speaks regularly to the gap between what conventional medicine offers patients with metabolic dysfunction and what a root-cause, functional approach can deliver when the right diagnostics and time are applied. Through Prime Vitality Care's HIPAA-compliant telehealth platform, Dr. Goel brings the same standard of clinical depth and personalization to patients nationwide that San Antonio patients have relied on in person — with lab coordination through local Quest Diagnostics or CPL sites and all prescriptions compounded and shipped directly to patients.

I am the Chief Medical Officer at Boomerang Health Care, a state of the art multidisciplinary specialty group offering interventional, surgical and rehabilitative care through its 25 clinics in California. I also serve as the Medical Director at Le Reve: Regen, a leader in cutting edge restorative and regenerative solutions for Spine, Orthopedics and Musculoskeletal conditions. In the academic world, I have served as a Clinical Faculty at Stanford University for more than 20 years and have established myself as a world leader in cutting edge innovative therapeutic solutions. I completed her Anesthesiology residency from Medical College of Wisconsin, Milwaukee and Fellowship in Pain Medicine from the University of California, Davis. I am board certified in Anesthesiology and Pain Medicine by American Board of Anesthesiology, in Interventional Pain by American Board of Interventional Pain Physicians and in Regenerative Medicine by American Board of Regenerative Medicine. I sit on the Editorial board of the journal, Pain Physician and serve on the board of the American Society of Interventional Pain Physicians, Latin American Pain Society, California Society of Industrial Medicine and Surgery, California Society of Interventional Pain Physicians and Scilex (Nasdaq: SCLX). I am humbled to receive the Distinguished Service Award, Outstanding Achievement Awards and other accolades. I have devoted my entire career to the field of Interventional spine and Regenerative medicine and have contributed via several peer reviewed journal articles, visionary editorials, and book chapters. My book, “Essentials of Regenerative Medicine” is first in its right illustrating latest interventional biologic techniques for spine and musculoskeletal injuries. I have also authored several National Guidelines including the ones on Opioids, Interventional Spine Epidural procedures, Facet joints, and the first ever on the Safe and Effective use of Biologics in Lumbar spine. I have completed the first prospective, multicenter, randomized placebo controlled trial demonstrating efficacy of platelet rich plasma and bone marrow concentrate in patients with back pain related to disc injury/degeneration. I consider myself an authority on global health care trends including digital health, technology innovations and applied biologics. Let’s connect and work together to make healthcare better, faster, and more effective – www.annunavani.com.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

SimplerQMS is a Pre-Validated eQMS for Life Science Companies. We help Pharma, Medical Device and MedTech companies save time and stay compliant with our easy-to-use cloud software. SimplerQMS is audit-ready and compliant with GxP, FDA, ICH, MDR, ISO27001 and certified according to ISO13485:2016.

As I am a medical expert for Invigor Medical, a urologist, and an MD currently completing my PhD in clinical medicine, my work bridges patient care, education, and research. I serve as a teaching assistant in surgery, where I guide and support future doctors while treating patients in everyday practice. My research focuses on oncologic urology, men’s health, and hormonal health, and I actively collaborate on international studies. Through these roles, I am dedicated to advancing evidence-based medicine, improving patient outcomes, and helping shape the future of urological care.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.